Best Practices, LLC initiated this benchmarking study to uncover how companies redesign their structures and assume leaner operational strategies that better reflect and support corporate values. Seven benchmark facilities were selected from sterile, pharmaceutical and chemical manufacturers as well as large pharmaceutical and biotechnology companies. Benchmark partners stress the critical importance of sound reorganization management. Business disruptions and distracted employees can sink the most effective new structure before it is even in place. Leading companies engage in extensive communication campaigns to gather employee input and secure buy-in for major reorganizations. Attaching compensation plans to reorganization success also proves effective in gaining widespread employee support. This seven-page document includes best practices that partners identified for designing the reorganization process, managing reorganization activities, communicating before, during and after reorganization, maintaining productivity during the reorganization process, and reviewing and revising reorganization goals.
This study will serve as a benchmark for pharmaceutical manufacturing facilities undergoing organizational redesign to manage a change process that allows the company to continue operations while implementing significant structural changes. It will provide insights into designing a reorganization process that sufficiently plans for changes to align strategy with corporate redesign.